| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
International Co-operation Laboratory on Signal Transduction (L.C., H.-X.Y., W.Y., Q.L., H.-F.C., S.-Q.L., H.-Y.W.), Eastern Hepatobiliary Surgery Institute, and Department of Surgery (B.Z., M.-C.W.), Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, 200438 Shanghai, Peoples Republic of China; and State Key Laboratory of Genetic Engineering (J.C.), Institute of Genetics, School of Life Science, Fudan University, 200433 Shanghai, Peoples Republic of China
Address all correspondence and requests for reprints to: Hong-yang Wang, M.D., International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, SMMU, 200438 Shanghai, Peoples Republic of China. E-mail: hywangk{at}vip.sina.com.
The pancreatic and duodenal homeobox factor-1 (Pdx1) is essential for pancreatic development and insulin gene transcription, whereas c-Myc has a deleterious effect on islet function. However, the relationship between c-Myc and Pdx1 is poorly concerned. Here we demonstrated that Pdx1 could suppress c-Myc promoter activity, which relied on T cell factor (Tcf) binding elements harbored in c-Myc promoter. Furthermore, the transcription activity of ß-catenin/Tcf was markedly decreased on Pdx1 expression, but cotransfection of Pdx1 short hairpin RNA abrogated this effect. Pdx1 expression did not induce ß-catenin degradation nor did it alter their subcellular distribution. The mutation analysis showed that the amino acids (1209) of Pdx1 harboring an inhibitory domain, which might lead to the reduction of ß-catenin/Tcf/p300 complex levels and attenuate their binding activity with c-Myc promoter sequences. Moreover, adenovirus-mediated Pdx1 interference caused cell proliferation and cytokine-induced apoptosis via the dysregulation of c-Myc transcription. These results indicated that the Pdx1 functioned as a key regulator for maintenance of ß-cell function, at least in part, through controlling c-Myc expression and the loss of its regulatory function may be an alternative mechanism for ß-cell neogenesis and apoptosis found in diabetes.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |